Skip to content

Study · Not a test of the peptide alone · 1987

1 result

4-Methoxybenzyloxycarbonyl amino acids in solid phase peptide synthesis.

Wang SS, Chen ST, Wang KT, Merrifield RB

International journal of peptide and protein research1 Nov 1987Cited by 5 (Europe PMC)

PMID3436702 (opens in a new tab)DOI10.1111/j.1399-3011.1987.tb03377.x (opens in a new tab)PepBankPUB-03436702
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01LabNot a test of Thymosin alpha-1 aloneIn vitro (cell-free)Other

    Moz-amino acids were used in solid-phase synthesis of thymosin alpha‑1, and the Moz-group was removed rapidly and completely with 5-10% TFA in CH2Cl2.

    In plain wordsIn lab chemistry, a protecting group called Moz was used to build thymosin alpha‑1 and was removed quickly with acid.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableMoz-amino acids in solid-phase synthesis
    Study

    n: not reported in source

    Outcome group
    Synthesis and manufacturing · Pharmacology

    Source sentences

    Summary
    Moz-amino acids were used in solid-phase synthesis of Leu-Ala-Gly-Val and thymosin alpha 1. It was found that the Moz-group can be removed rapidly and completely with 5-10% TFA in CH2Cl2.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.